{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:08:06Z","timestamp":1759018086968,"version":"3.44.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.jinf.2006.12.005","type":"journal-article","created":{"date-parts":[[2007,1,23]],"date-time":"2007-01-23T07:58:09Z","timestamp":1169539089000},"page":"75-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Soluble CD26 and CD30 levels in patients with anthroponotic cutaneous leishmaniasis"],"prefix":"10.1016","volume":"55","author":[{"given":"Soheila","family":"Ajdary","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Jafari-Shakib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhad","family":"Riazi-Rad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Khamesipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2006.12.005_bib1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0738-081X(99)00006-1","article-title":"Cutaneous leishmaniasis in the Middle East","volume":"17","author":"Klaus","year":"1999","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jinf.2006.12.005_bib2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0738-081X(99)00047-4","article-title":"Cutaneous leishmaniasis: clinical features and diagnosis","volume":"17","author":"Salman","year":"1999","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jinf.2006.12.005_bib3","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1365-4362.1994.tb01039.x","article-title":"Clinical picture of cutaneous leishmaniasis in Isfahan, Iran","volume":"33","author":"Momeni","year":"1994","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jinf.2006.12.005_bib4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0738-081X(96)00058-2","article-title":"Cutaneous leishmaniasis: clinical aspect","volume":"14","author":"Dowlati","year":"1996","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jinf.2006.12.005_bib5","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJM199305133281904","article-title":"Visceral infection caused by Leishmania tropica in veterans of operation desert storm","volume":"328","author":"Magill","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2006.12.005_bib6","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1128\/IAI.68.4.1760-1764.2000","article-title":"Comparison of the immune profile of non-healing cutaneous leishmaniasis patients with those with active lesions and those who have recovered from infection","volume":"68","author":"Ajdary","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.jinf.2006.12.005_bib7","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/0035-9203(93)90030-T","article-title":"The clinical and immunological spectrum of American cutaneous leishmaniasis","volume":"87","author":"Convit","year":"1993","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.jinf.2006.12.005_bib8","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1128\/iai.62.3.837-842.1994","article-title":"Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasis","volume":"62","author":"Melby","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.jinf.2006.12.005_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0001-706X(02)00260-7","article-title":"Mucosal leishmaniasis: in situ characterization of the host inflammatory response, before and after treatment","volume":"85","author":"Amato","year":"2003","journal-title":"Acta Trop"},{"key":"10.1016\/j.jinf.2006.12.005_bib10","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.4049\/jimmunol.135.6.4144","article-title":"Cell mediated immunity in American cutaneous and mucosal leishmaniasis","volume":"135","author":"Carvalho","year":"1985","journal-title":"J Immunol"},{"key":"10.1016\/j.jinf.2006.12.005_bib11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.0105-2896.2004.00185.x","article-title":"Re-examination of the immunosuppressive mechanisms mediating non-cure of Leishmania infection in mice","volume":"201","author":"Sacks","year":"2004","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jinf.2006.12.005_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0167-5699(94)90316-6","article-title":"CD26: a surface protease involved in T-cell activation","volume":"15","author":"Fleischer","year":"1994","journal-title":"Immunol Today"},{"key":"10.1016\/j.jinf.2006.12.005_bib13","first-page":"685","article-title":"CD26 expression in leprosy and other granulomatous diseases correlation with the production of IFN-\u03b3","volume":"73","author":"Scheel-Toellner","year":"1995","journal-title":"Lab Invest"},{"key":"10.1016\/j.jinf.2006.12.005_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jneuroim.2006.09.006","article-title":"CD4+ memory T cells with high CD26 surface expression are enriched for Th1 markers and correlate with clinical severity of multiple sclerosis","volume":"181","author":"Krakauer","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jinf.2006.12.005_bib15","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1006\/cyto.1999.0643","article-title":"Mechanisms of CD26\/dipeptidyl peptidase in cytokine-dependent regulation on human activated lymphocytes","volume":"12","author":"Salgado","year":"2000","journal-title":"Cytokine"},{"key":"10.1016\/j.jinf.2006.12.005_bib16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1096\/fasebj.9.1.7821763","article-title":"Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokine","volume":"9","author":"Del Prete","year":"1995","journal-title":"FASEB J"},{"key":"10.1016\/j.jinf.2006.12.005_bib17","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/jlb.57.5.726","article-title":"CD30 and type 2 T helper (Th2) responses","volume":"57","author":"Romagnani","year":"1995","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jinf.2006.12.005_bib18","first-page":"1372","article-title":"Concentrations of cytokines, soluble interleukin-2 receptor, and soluble CD30 in sera of patients with hepatitis B virus infection during acute and convalescent phases","volume":"9","author":"Monsalve-De Castillo","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.jinf.2006.12.005_bib19","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1006\/cyto.1999.0653","article-title":"Soluble CD30 serum level in HCV-positive chronic active hepatitis: a surrogate marker of disease activity?","volume":"12","author":"Foschi","year":"2000","journal-title":"Cytokine"},{"key":"10.1016\/j.jinf.2006.12.005_bib20","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jaci.2006.07.014","article-title":"Direct evidence for a critical role of CD30 in the development of allergic asthma","volume":"118","author":"Polte","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jinf.2006.12.005_bib21","first-page":"1858","article-title":"Reduction of serum soluble CD26\/dipeptidyl IV enzyme activity and its correlation with disease activity in systemic lupus erythematosus","volume":"29","author":"Kobayashi","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jinf.2006.12.005_bib22","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1034\/j.1398-9995.2001.00137.x","article-title":"The role of CD30 in atopic disease","volume":"56","author":"Bengtsson","year":"2001","journal-title":"Allergy"},{"key":"10.1016\/j.jinf.2006.12.005_bib23","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1046\/j.1365-2249.1997.4731373.x","article-title":"Elevated serum levels of soluble CD30 in patients with atopic dermatitis (AD)","volume":"109","author":"Bengtsson","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jinf.2006.12.005_bib24","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nri933","article-title":"The immunology of susceptibility and resistance to Leishmania major in mice","volume":"2","author":"Sacks","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jinf.2006.12.005_bib25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.iy.13.040195.001055","article-title":"The regulation of immunity to Leishmania major","volume":"13","author":"Reiner","year":"1995","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jinf.2006.12.005_bib26","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000010328","article-title":"Changes in plasma soluble CD26 and CD30 during pregnancy: markers of Th1\/Th2 balance?","volume":"50","author":"Hoshimoto","year":"2000","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.jinf.2006.12.005_bib27","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/j.1365-2133.1996.tb07941.x","article-title":"Keratinocytes express dipeptidyl-peptidase IV (CD26) in benign and malignant skin diseases","volume":"134","author":"Novelli","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jinf.2006.12.005_bib28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1365-2249.2000.01286.x","article-title":"Soluble CD30 is more relevant to disease activity of atopic dermatitis than soluble CD26","volume":"121","author":"Katoh","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jinf.2006.12.005_bib29","first-page":"67","article-title":"Soluble CD26\/30 levels before and after treatment with INF-\u03b1 and ribavirin combination therapy in a pediatric hepatitis C patient","volume":"37","author":"Liao","year":"2004","journal-title":"J\u00a0Microbiol Immunol Infect"},{"key":"10.1016\/j.jinf.2006.12.005_bib30","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1399-3038.2006.00405.x","article-title":"Soluble CD30 serum levels in atopic dermatitis and bronchial asthma and its relation with disease severity in pediatric age","volume":"17","author":"Heshmat","year":"2006","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jinf.2006.12.005_bib31","first-page":"457","article-title":"Circulating cytokines and soluble CD23, CD26 and CD30 in ANCA-associated vasculitides","volume":"18","author":"Schonermarck","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jinf.2006.12.005_bib32","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2249.2006.03105.x","article-title":"Soluble CD26\/CD30 levels in visceral leishmaniasis: marker of disease activity","volume":"145","author":"Ajdary","year":"2006","journal-title":"Clin Exp Immunol"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445306004208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445306004208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:30:54Z","timestamp":1758987054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445306004208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0163445306004208"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2006.12.005","relation":{},"ISSN":["0163-4453"],"issn-type":[{"type":"print","value":"0163-4453"}],"subject":[],"published":{"date-parts":[[2007,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soluble CD26 and CD30 levels in patients with anthroponotic cutaneous leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2006.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 The British Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}